Tag: GlaxoSmithKline
January 13, 2020
23andMe Working on New Drug Based on Users’ Genetics
23andMe is teaming up with Spanish drugmaker Almirall to develop an antibody that treats certain inflammatory diseases using customer data.
January 6, 2020
Pharma Outlook 2020: Oncology Commands Sector Growth
At the dawn of a new year, INN offers a preview of potential developments in the pharmaceutical market throughout 2020.
October 2, 2019
GlaxoSmithKline Files NDA for Inhaler to Treat Asthma
The company's inhaler therapy, Trelegy Ellipta, has already been approved in the US for chronic obstructive pulmonary disease. September 10, 2019
VBI Vaccines Announces Phase 2a Clinical Evaluation of VBI-1901
VBI Vaccines (NASDAQ:VBI) has announced a collaboration with GlaxoSmithKline (NYSE:GSK) to evaluate VBI’s VBI-1901 with GSK’s AS01 adjuvant system. As...
August 29, 2019
AstraZeneca’s Lupus Drug Finally Meets Endpoints in Phase 3 Trial
The victory comes almost exactly a year after AstraZeneca's lupus treatment didn't meet its primary endpoints in a different trial.
August 28, 2019
10 Top Pharma Companies by Revenue
We break down the top pharma companies by revenue in 2018, according to information from research firm GlobalData.
August 15, 2019